M Rainer

Summary

Country: Austria

Publications

  1. ncbi request reprint [State of the art management of BPSD in dementia]
    Michael K Rainer
    Memory Klinik und Psychiatrische Abteilung, Donauspital, Sozialmedizinisches Zentrum Ost, Wien, Osterreich
    Psychiatr Prax 32:31-8. 2005
  2. ncbi request reprint Data from the VITA Study do not support the concept of vascular depression
    Michael K Rainer
    Danube Hospital, Vienna, Austria
    Am J Geriatr Psychiatry 14:531-7. 2006
  3. doi request reprint Ginkgo biloba extract EGb 761 in the treatment of dementia: a pharmacoeconomic analysis of the Austrian setting
    Michael Rainer
    Department of Psychiatry, Memory Clinic, Sozialmedizinisches Zentrum Ost Donauspital, Karl Landsteiner Institut für Gedächtnis und Alzheimer Forschung, Langobardenstrasse 122, 1220 Vienna, Austria
    Wien Klin Wochenschr 125:8-15. 2013
  4. ncbi request reprint [Memory clinics in Austria - characteristics and patterns of practice]
    Michael Rainer
    Karl Landsteiner Institut für Gedächtnis und Alzheimerforschung und Memory Clinic, Sozialmedizinisches Zentrum Ost
    Neuropsychiatr 25:9-15. 2011
  5. doi request reprint Memantine in moderate to severe Alzheimer's disease: an observational post-marketing study
    Michael Rainer
    Memory Clinic and Psychiatric Department, Donauspital Sozialmedizinisches Zentrum Ost, Langobardenstrasse 122, 1220, Wien, Austria
    J Neural Transm 118:1255-9. 2011
  6. ncbi request reprint Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function
    M Rainer
    Psychiatric Department and Memory Clinic, Danube Hospital, Langobardenstrasse 122, A 1220 Vienna, Austria
    Eur Psychiatry 22:395-403. 2007
  7. ncbi request reprint [The geriatric psychiatry patient--a new indications field for psychotherapy?]
    Michael Rainer
    Psychiatrische Abteilung und Memory Clinic, Donauspital im SMZ Ost der Stadt Wien, Langobardenstrasse 122, 1220 Wien, Osterreich
    Wien Med Wochenschr 153:506-11. 2003
  8. ncbi request reprint Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics
    M Rainer
    Memory-Clinic and Department of Psychiatry, Donauspital, Sozialmedizinisches Zentrum Ost, Vienna, Austria
    J Neural Transm 108:1327-33. 2001
  9. ncbi request reprint Alcohol-induced organic cerebral psychosyndromes: partial reversal of cognitive impairments assisted by dihydroergocristine
    M Rainer
    Donauspital, Sozialmedizinisches Zentrum Ost, Wien, Austria
    Psychopharmacology (Berl) 127:365-9. 1996
  10. doi request reprint Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study
    Edna Grunblatt
    Ludwig Boltzmann Society, L Boltzmann Institute of Aging Research, Vienna, Austria
    J Psychiatr Res 43:298-308. 2009

Detail Information

Publications12

  1. ncbi request reprint [State of the art management of BPSD in dementia]
    Michael K Rainer
    Memory Klinik und Psychiatrische Abteilung, Donauspital, Sozialmedizinisches Zentrum Ost, Wien, Osterreich
    Psychiatr Prax 32:31-8. 2005
    ..To obtain a cross-sectional overview of therapeutic practice concerning non-cognitive, behavioral signs and symptoms of dementia (BPSD) in Germany, Austria, and Switzerland...
  2. ncbi request reprint Data from the VITA Study do not support the concept of vascular depression
    Michael K Rainer
    Danube Hospital, Vienna, Austria
    Am J Geriatr Psychiatry 14:531-7. 2006
    ..The objective of this study was to investigate whether deep white matter or periventricular hyperintensities, small ischemic lesions, and brain atrophy contribute to late-onset depression in the nondemented elderly...
  3. doi request reprint Ginkgo biloba extract EGb 761 in the treatment of dementia: a pharmacoeconomic analysis of the Austrian setting
    Michael Rainer
    Department of Psychiatry, Memory Clinic, Sozialmedizinisches Zentrum Ost Donauspital, Karl Landsteiner Institut für Gedächtnis und Alzheimer Forschung, Langobardenstrasse 122, 1220 Vienna, Austria
    Wien Klin Wochenschr 125:8-15. 2013
    ..In a separate analysis, we compared the pharmacoeconomic aspects of achieving treatment success with EGb 761R and cholinesterase inhibitors...
  4. ncbi request reprint [Memory clinics in Austria - characteristics and patterns of practice]
    Michael Rainer
    Karl Landsteiner Institut für Gedächtnis und Alzheimerforschung und Memory Clinic, Sozialmedizinisches Zentrum Ost
    Neuropsychiatr 25:9-15. 2011
    ..Interest in a potential cross-border collaboration of Memory Clinics in German-speaking countries is almost universal...
  5. doi request reprint Memantine in moderate to severe Alzheimer's disease: an observational post-marketing study
    Michael Rainer
    Memory Clinic and Psychiatric Department, Donauspital Sozialmedizinisches Zentrum Ost, Langobardenstrasse 122, 1220, Wien, Austria
    J Neural Transm 118:1255-9. 2011
    ..Treatment effects were apparent in both pre-treated and treatment-naïve patient subgroups...
  6. ncbi request reprint Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function
    M Rainer
    Psychiatric Department and Memory Clinic, Danube Hospital, Langobardenstrasse 122, A 1220 Vienna, Austria
    Eur Psychiatry 22:395-403. 2007
    ....
  7. ncbi request reprint [The geriatric psychiatry patient--a new indications field for psychotherapy?]
    Michael Rainer
    Psychiatrische Abteilung und Memory Clinic, Donauspital im SMZ Ost der Stadt Wien, Langobardenstrasse 122, 1220 Wien, Osterreich
    Wien Med Wochenschr 153:506-11. 2003
    ..This definition of psychotherapy makes it obvious that demented and care-dependent patients are potential candidates for psychotherapy...
  8. ncbi request reprint Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics
    M Rainer
    Memory-Clinic and Department of Psychiatry, Donauspital, Sozialmedizinisches Zentrum Ost, Vienna, Austria
    J Neural Transm 108:1327-33. 2001
    ..Its magnitude was comparable to the cognitive response observed in published clinical trials when cholinesterase therapy commenced, and also with the data obtained during a 6-week placebo washout phase...
  9. ncbi request reprint Alcohol-induced organic cerebral psychosyndromes: partial reversal of cognitive impairments assisted by dihydroergocristine
    M Rainer
    Donauspital, Sozialmedizinisches Zentrum Ost, Wien, Austria
    Psychopharmacology (Berl) 127:365-9. 1996
    ..Based on this profile of efficacy and safety, we recommend dihydroergocristine as an adjuvant drug in alcohol rehabilitation...
  10. doi request reprint Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study
    Edna Grunblatt
    Ludwig Boltzmann Society, L Boltzmann Institute of Aging Research, Vienna, Austria
    J Psychiatr Res 43:298-308. 2009
    ..In this study, we attempted to find various factors and markers for both AD and depression in a longitudinal cohort, the Vienna-Transdanube-Aging (VITA)-study...
  11. ncbi request reprint Zotepine for behavioural and psychological symptoms in dementia: an open-label study
    Michael K Rainer
    Memory Clinic and Psychiatric Department, Donauspital, Sozialmedizinisches Zentrum Ost, Vienna, Austria
    CNS Drugs 18:49-55. 2004
    ..To provide initial information on the safety and efficacy of the atypical antipsychotic zotepine in the treatment of behavioural and psychological symptoms of dementia (BPSD)...
  12. ncbi request reprint Zotepine for behavioural and psychological symptoms in dementia: an open-label study
    Michael K Rainer
    CNS Drugs 18:1165. 2004